Abstract:Intellectual disability with speech delay and behavioural abnormalities, as well as hypotonia, seizures, feeding difficulties and craniofacial dysmorphism, are the main symptoms associated with pathogenic variants of the ZMYND11 gene. The range of clinical manifestations of the ZMYND phenotype is constantly being expanded by new cases described in the literature. Here, we present two previously unreported paediatric patients with neurodevelopmental challenges, who were diagnosed with missense variants in the ZMYND11 gene. It should be noted that one of the individuals manifested with hyperinsulinaemic hypoglycaemia (HH), a symptom that was not described before in published works. The reason for the occurrence of HH in our proband is not clear, so we try to explain the origin of this symptom in the context of the ZMYND11 syndrome. Thus, this paper contributes to knowledge on the range of possible manifestations of the ZMYND disease and provides further evidence supporting its association with neurodevelopmental challenges.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to further clarify the clinical phenotypes of patients with ZMYND11 gene variants in neurodevelopmental malformation syndromes. Specifically, by reporting two previously unreported pediatric cases, the researchers explored the new clinical symptoms that occur in these patients, especially the hyperinsulinemic hypoglycemia (HH) symptom that had not been described in previous literature in one of the cases. The study aims to expand the understanding of the possible manifestation range of ZMYND11 - related diseases and provide evidence for further demonstrating its association with neurodevelopmental disorders. ### Research Background The ZMYND11 gene encodes a protein containing a zinc - finger MYND domain. As a transcriptional co - repressor, it inhibits the elongation phase of RNA polymerase II by recognizing histone modifications in the transcriptional region. It is known that the ZMYND11 gene plays a key role in 10p15.3 microdeletion syndrome, which is associated with neurodevelopmental disorders, malformation features, hypotonia, and seizures. In addition, heterozygous pathogenic variants of the ZMYND11 gene have been identified as the cause of autosomal dominant intellectual developmental disorder - 30 (MRD30) with speech delay and behavioral abnormalities. ### Main Findings 1. **Case 1**: - **Clinical Features**: Developmental delay (especially in language), malformation features, short stature. - **New Findings**: Transient hypoglycemia and hyperinsulinemic hypoglycemia (HH) that occurred at the age of 5, which had not been reported in previous literature. 2. **Case 2**: - **Clinical Features**: Severe global developmental delay, feeding difficulties, malformation features, hyperinsulinemic hypoglycemia (HH). - **New Findings**: Hyperinsulinemic hypoglycemia (HH), which was reported for the first time in patients with ZMYND11 variants. ### Significance - **Expansion of Clinical Phenotypes**: Through the reports of these two cases, the study has expanded the range of clinical manifestations of ZMYND11 - related diseases, especially the new symptom of hyperinsulinemic hypoglycemia (HH). - **Mechanism Exploration**: The study attempts to explain the origin of hyperinsulinemic hypoglycemia (HH) in ZMYND11 syndrome, providing clues for further understanding the pathological mechanism of this disease. - **Diagnosis and Treatment**: These findings are helpful for improving doctors' awareness of the diagnosis of ZMYND11 - related diseases and providing new ideas for the management and treatment of patients. In conclusion, through detailed case reports and genetic analysis, this paper provides new insights into the clinical manifestations of ZMYND11 gene variants in neurodevelopmental malformation syndromes, especially emphasizing the newly discovered symptom of hyperinsulinemic hypoglycemia (HH).

Further Delineation of Clinical Phenotype of ZMYND11 Variants in Patients with Neurodevelopmental Dysmorphic Syndrome

Mutation in ZDHHC15 Leads to Hypotonic Cerebral Palsy, Autism, Epilepsy, and Intellectual Disability

MYT1L-associated neurodevelopmental disorder: description of 40 new cases and literature review of clinical and molecular aspects

Heterozygous ANKRD17 loss-of-function variants cause a syndrome with intellectual disability, speech delay, and dysmorphism

Deep phenotyping of 11 individuals with pathogenic variants in RNU4-2 reveals a clinically recognizable syndrome

Epigenomic and phenotypic characterization of DEGCAGS syndrome

Extended phenotypic characterization of a novel Helsmoortel‐van der Aa syndrome case series

Expanding the phenotype of PPP1R21‐related neurodevelopmental disorder

A case report of a patient with neurodevelopmental disorder with impaired speech and hyperkinetic movements: A biallelic variant in the ZNF142 gene

Admixed phenotype of NEDD4L associated periventricular nodular heterotopia: A case report

Clinical and genetic characterization of patients segregating variants in KPTN, MINPP1, NGLY1, AP4B1, and SON underlying neurodevelopmental disorders: Genetic and phenotypic expansion

Genotype–phenotype correlations and novel molecular insights into the DHX30-associated neurodevelopmental disorders

Novel Variants of PPP2R1A in Catalytic Subunit Binding Domain and Genotype–Phenotype Analysis in Neurodevelopmentally Delayed Patients

Further delineation of the rare GDACCF (global developmental delay, absent or hypoplastic corpus callosum, dysmorphic facies syndrome): genotype and phenotype of 22 patients with ZNF148 mutations

BCL11A intellectual developmental disorder: defining the clinical spectrum and genotype-phenotype correlations

Further Delineation of the Proximal 16p11.2 Microdeletion Syndrome: Novel Findings Among 22 New Individuals

Clinical and molecular characterization of patients with YWHAG‐related epilepsy

SYN1 variant causes X-linked neurodevelopmental disorders: a case report of variable clinical phenotypes in siblings

Disruption of PHF21A causes syndromic intellectual disability with craniofacial anomalies, epilepsy, hypotonia, and neurobehavioral problems including autism

Expanding the phenotypic spectrum of MPDZ gene variants: A case report with prenatally detected Dandy–Walker malformation and single ventricle heart

Biallelic loss-of-function variants in CACHD1 cause a novel neurodevelopmental syndrome with facial dysmorphism and multisystem congenital abnormalities